Retail Price: €39.00 Interested in Wholesale Pricing?
Why You Should Buy NOLVO® (Tamoxifen Citrate) at FULMEN Pharma?
Here at FULMEN Pharma every single day we strive to deliver immaculate German quality anabolic steroids and HGH for our valued customer by ensuring uninterrupted human eye control on all the processes, post-production tests and examinations followed by a strict each product inspection before shipment. We are absolutely confident about your NOLVO® (Tamoxifen Citrate) product satisfaction and online shopping experience!
About NOLVO® (Tamoxifen Citrate) Product
The use of Tamoxifen Citrate has been utilized in the treatment of metastatic breast cancer (breast cancer which can expand to other parts of the body). It is also used in radiation therapy to reduce the chances of breast cancer in high-risk patients. The medication works by interfering with the effects of estrogen in the breast tissue. It also blocks the actions of estrogen; a female hormone and scientific research have shown that breast cancer requires estrogen to grow. The use of Tamoxifen Citrate is not only limited to the treatment of breast cancer in men and women. It tends to lower the chance of a woman’s possibility of developing breast cancer. It is most common among individuals who have a family history of breast cancer.
The other non-medical use of NOLVO® (Tamoxifen Citrate) has been utilized in bodybuilding and as a performance-enhancing drug among athletes. Tamoxifen Citrate is sold under the brand name NOLVO® among others. Tamoxifen Citrate is administered orally. Tamoxifen Citrate was introduced in 1962 by Dora Richardson (a chemist). It is among the World Health Organization’s list of essential medicines. It is one of the most effective and safe medications which are needed in a health system. It is available in different forms of generic medications.
NOLVO® (Tamoxifen Citrate) is s prodrug with a relatively low affinity for the estrogen receptor (ER); its target protein. Tamoxifen Citrate is metabolized in the liver into active metabolites such as 4-hydroxytamoxifen; 4-OHT (afimoxifene) and endoxifen. The latter component has 30 to 100 times affinity for the ER than the former. In the breast tissue, the 4-OHT acts an ER antagonist which brings about an inhibition in the transcription of estrogen-responsive genes. Tamoxifen Citrate functions as an active metabolite of tamoxifen which has been known to act as potent competitive aromatase inhibitors and is involved in antiestrogenic activities. It has been found to decrease the levels of insulin-growth factor 1 in men and women.
The side effects associated with the use of NOLVO® (Tamoxifen Citrate) has been identified in the increased risk of uterine pulmonary embolism, challenges with vision, cancer and uterine cancer. The other common forms of side reactions experienced in the use of Tamoxifen Citrate include; hot flashes, weight loss and irregular periods. When taken during pregnancy, Tamoxifen Citrate has a high tendency of causing harm to the baby when taken while breastfeeding or pregnancy. Since Tamoxifen Citrate is a selective estrogen-receptor modulator (SERM), it works by decreasing the growth of cancerous cells and in the acquiring body mass in men. The dosage of NOLVO® depends on the intended use and the type of underlying health condition it seeks to treat. In most cases, the dosage range from 20 mg to 40 mg which is administered orally divided into two doses.
In summary, each bottle of NOLVO® (Tamoxifen Citrate) contains 100 tablets with a concentration of 16 mg of the substance.